GT Biopharma GTBP
NASDAQ GTBP
$6.98 +0.18 (+2.65%)
As of: Sep 30, 2026 · 10:18 AM EDT

GT Biopharma (GTBP) Gross Margin (2010 - 2015)

Updated

GT Biopharma (GTBP) reported Gross Margin of 100.00% for FY2015, up 93.44 percentage points from 6.56% in FY2014.

Analysis

GT Biopharma (GTBP) Gross Margin (2010 - 2015) Analysis & Trends

Dating back to FY2010, GT Biopharma's Gross Margin record includes 5 years.

  • Gross Margin has a five-year change of +590.91 percentage points (FY2010 to FY2015).
  • The FY2015 figure ranks as the highest annual Gross Margin in data going back to FY2010.
  • According to Business Quant data, Gross Margin came in at 6.56% in FY2014, 72.51% in FY2012 (+157.13 pp) and -84.62% in FY2011 (+406.29 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 GT Biopharma 9.57 Mn 9.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 100.00%
Mar 31, 2015 100.00%
Mar 31, 2013 21.59%
Dec 31, 2012 72.15%
Sep 30, 2012 73.33%
Jun 30, 2012 100.00%
Dec 31, 2011 100.00%
Sep 30, 2011 -300.00%
Jun 30, 2011 -1,400.00%
Mar 31, 2011 -25.00%
Dec 31, 2010 -490.91%
API Access

GT Biopharma Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=GTBP&period=max&api_key=YOUR_API_KEY